These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension. Sasaki J, Kajiyama G, Kusukawa R, Mori H, Koga S, Takagi R, Tanaka N, Ogawa N, Arakawa K. Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705 [Abstract] [Full Text] [Related]
4. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril. Middeke M, Richter WO, Schwandt P, Holzgreve H. Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337 [Abstract] [Full Text] [Related]
5. [Serum lipid levels under chronical treatment with beta-receptor blocking agents in patients with coronary artery disease (author's transl)]. Merker R, Schwittek W, Kladetzky RG, Kuhn H. Z Kardiol; 1981 Jun; 70(6):455-61. PubMed ID: 6114600 [Abstract] [Full Text] [Related]
6. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model. Balasubramaniam S, Simons LA, Hickie JB, Chang S. Artery; 1990 Jun; 17(2):60-70. PubMed ID: 1968740 [Abstract] [Full Text] [Related]
12. Effects of anti-hypertensive therapy on serum lipoproteins. Treatment with metoprolol, propranolol and hydrochlorothiazide. Fager G, Berglund G, Bondjers G, Elmfeldt D, Lager I, Olofsson SO, Smith U, Wiklund O. Artery; 1983 Dec; 11(4):283-96. PubMed ID: 6615245 [Abstract] [Full Text] [Related]
13. [Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives]. Rouffy J, Chanu B, Bakir R, Sauvanet JP. J Pharmacol; 1983 Dec; 14 Suppl 2():183-99. PubMed ID: 6138467 [Abstract] [Full Text] [Related]
15. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus. Petersen KR. Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723 [Abstract] [Full Text] [Related]
16. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus. Romics L, Karádi I, Rozenberczki M, Kammerer L. Acta Med Acad Sci Hung; 1982 Feb; 39(3-4):117-23. PubMed ID: 6764327 [Abstract] [Full Text] [Related]
17. The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone. Helgeland A. J Cardiovasc Pharmacol; 1984 Feb; 6 Suppl 3():S474-6. PubMed ID: 6208414 [Abstract] [Full Text] [Related]
18. [Bopindolol does not affect normal glucose and lipid metabolism in hypertensive patients]. Fedelesová V, Spustová V, Hucková M, Kovác G. Vnitr Lek; 1989 Sep; 35(9):873-9. PubMed ID: 2573194 [Abstract] [Full Text] [Related]
19. Blood lipids and antihypertensive drugs. The Oslo study. Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG. J Pharmacol; 1983 Sep; 14 Suppl 2():217-20. PubMed ID: 6632918 [Abstract] [Full Text] [Related]
20. Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension. Bagatin J, Sardelić S, Pivac N, Polić S, Ljutic D, Rakic D, Naranca M, Bojić L, Kovacić Z, Rumboldt Z. Int J Clin Pharmacol Res; 1998 Sep; 18(2):73-8. PubMed ID: 9675624 [Abstract] [Full Text] [Related] Page: [Next] [New Search]